XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.

Research

XyloCor Therapeutics

XyloCor Therapeutics' headquarters in Malvern, PA, United States

Albert Gianchetti

Michael C.

Rémi Gloeckler

Howard Dittrich

Alexander Gaidamaka

Ronald Crystal

Todd Rosengart

Alan Colowick

Nikhil Thatte

Lizzie Ngo

Aidan King

John de Koning

Daniel Hetu

Glenn Batchelder

Fouad Azzam

Advisory and Governance

Leadership Team

XyloCor Therapeutics

Org chart

Board & advisors

Teams

Advisory and Governance

Leadership Team

Offices

Similar companies